Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming Chyi Huang

Showing results (81-90 of 179) with videos related to

Pageof 18
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 16, 2011
Association of plasma retinol-binding protein-4, adiponectin, and high molecular weight adiponectin with metabolic adversities in patients with schizophreniaPo-Yu Chen, Ming-Chyi Huang, Chih-Chiang Chiu, et al.
Journal of Clinical Psychopharmacology|January 19, 2002
Shifting from haloperidol to risperidone for behavioral disturbances in dementia: safety, response predictors, and mood effectsHsien-Yuan Lane, Yue-Cune Chang, Muh-Hwan Su, et al.
Accident; Analysis and Prevention|November 4, 2019
Different demographic and drinking profiles of motorcyclists and car drivers with the first-time offense of driving/riding under the influence of alcoholYen-Chun Kuo, Lian-Yu Chen, Hu-Ming Chang, et al.
Comprehensive Psychiatry|December 9, 2008
Chinese version of the Delirium Rating Scale-Revised-98: reliability and validityMing-Chyi Huang, Chun-Hung Lee, Ying-Ching Lai, et al.
Psychiatry Research|August 31, 2015
Early treatment response predicted subsequent clinical response in patients with schizophrenia taking paliperidone extended-releaseEn-Chi Yeh, Ming-Chyi Huang, Chang-Jer Tsai, et al.
Substance Abuse Treatment, Prevention, and Policy|July 8, 2024
Psychometric validation of the Chinese Version of the stimulant relapse risk scale (SRRS) in patients with methamphetamine use disorderJing-Shu Lin, Yasukazu Ogai, Chun Lin, et al.
Journal of Substance Use and Addiction Treatment|February 21, 2023
Risk factors for relapse among methamphetamine users receiving a joint legal-medical treatment program as a diversion intervention: A one-year follow-up studyMing-Chyi Huang, Su-Chen Fang, Chun Lin, et al.
Scientific Reports|July 6, 2026
Gut microbiome dynamics and alcohol use outcomes during naltrexone treatment: a 12 week follow-up studyXiao-Ling Liu, Shih-Chun Meng, Yan-Jiun Hung, et al.
Psychopharmacology|August 5, 2019
Chronic ketamine abuse is associated with orexin-A reduction and ACTH elevationMing-Chyi Huang, Chun-Hsin Chen, Lian-Yu Chen, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|March 30, 2021
Neurofilament light chain as novel blood biomarker of disturbed neuroaxonal integrity in patients with ketamine dependenceYu-Li Liu, Francesco Bavato, An-Nie Chung, et al.
Pageof 18

Showing results (81-90 of 179) with videos related to

Sort By:
Pageof 18
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 16, 2011
Association of plasma retinol-binding protein-4, adiponectin, and high molecular weight adiponectin with metabolic adversities in patients with schizophreniaPo-Yu Chen, Ming-Chyi Huang, Chih-Chiang Chiu, et al.
Journal of Clinical Psychopharmacology|January 19, 2002
Shifting from haloperidol to risperidone for behavioral disturbances in dementia: safety, response predictors, and mood effectsHsien-Yuan Lane, Yue-Cune Chang, Muh-Hwan Su, et al.
Accident; Analysis and Prevention|November 4, 2019
Different demographic and drinking profiles of motorcyclists and car drivers with the first-time offense of driving/riding under the influence of alcoholYen-Chun Kuo, Lian-Yu Chen, Hu-Ming Chang, et al.
Comprehensive Psychiatry|December 9, 2008
Chinese version of the Delirium Rating Scale-Revised-98: reliability and validityMing-Chyi Huang, Chun-Hung Lee, Ying-Ching Lai, et al.
Psychiatry Research|August 31, 2015
Early treatment response predicted subsequent clinical response in patients with schizophrenia taking paliperidone extended-releaseEn-Chi Yeh, Ming-Chyi Huang, Chang-Jer Tsai, et al.
Substance Abuse Treatment, Prevention, and Policy|July 8, 2024
Psychometric validation of the Chinese Version of the stimulant relapse risk scale (SRRS) in patients with methamphetamine use disorderJing-Shu Lin, Yasukazu Ogai, Chun Lin, et al.
Journal of Substance Use and Addiction Treatment|February 21, 2023
Risk factors for relapse among methamphetamine users receiving a joint legal-medical treatment program as a diversion intervention: A one-year follow-up studyMing-Chyi Huang, Su-Chen Fang, Chun Lin, et al.
Scientific Reports|July 6, 2026
Gut microbiome dynamics and alcohol use outcomes during naltrexone treatment: a 12 week follow-up studyXiao-Ling Liu, Shih-Chun Meng, Yan-Jiun Hung, et al.
Psychopharmacology|August 5, 2019
Chronic ketamine abuse is associated with orexin-A reduction and ACTH elevationMing-Chyi Huang, Chun-Hsin Chen, Lian-Yu Chen, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|March 30, 2021
Neurofilament light chain as novel blood biomarker of disturbed neuroaxonal integrity in patients with ketamine dependenceYu-Li Liu, Francesco Bavato, An-Nie Chung, et al.
Pageof 18